Assessment of the MFSAF v4.0 and PROMIS Fatigue 7a to Measure Outcomes in Myelofibrosis: Validation from a Non-interventional Mixed Methods Study

ADVANCES IN THERAPY · Published 2026-06-12 · DOI 10.1007/s12325-026-03651-y

Free full text

Authors (10)

Amy Howerter, Helen Doll, Angela Stroupe, Elektra J. Papadopoulos, Avijeet S. Chopra, Kavita Sail, Kristina Fitzgerald, Chad Gwaltney, John Mascarenhas, Ruben Mesa

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Howerter, A., Doll, H., Stroupe, A., et al. (2026). Assessment of the MFSAF v4.0 and PROMIS Fatigue 7a to Measure Outcomes in Myelofibrosis: Validation from a Non-interventional Mixed Methods Study. ADVANCES IN THERAPY. https://doi.org/10.1007/s12325-026-03651-y

Related articles

• Factors Associated with Favorable One-Year Outcomes After PreserFlo MicroShunt Implantation: Insights from Anterior Segment Optical Coherence Tomography · ADVANCES IN THERAPY · 2026 · Same journal
• Uncontrolled Hypertension Prevalence, Characteristic Profiles, and Risk of Cardiorenal and Metabolic Outcomes: Insights from the EnligHTN Study · ADVANCES IN THERAPY · 2026 · Same journal
• Diagnostic Delay in Multiple Sclerosis in China: A Nationwide Cross-Sectional Study · ADVANCES IN THERAPY · 2026 · Same journal
• Usability and Acceptance of Autoinjector and Prefilled Syringe Devices by Patients with Generalized Myasthenia Gravis in a Human Factors Study · ADVANCES IN THERAPY · 2026 · Same journal
• Long-Term Effects of Exercise During Pregnancy on the Metabolic Health of Mothers with Overweight/Obesity and Their Offspring: An 8- to 10-Year Follow-Up Study · ADVANCES IN THERAPY · 2026 · Same journal
• Expert Consensus on the Clinical Application of Sulodexide in Vascular Diseases · ADVANCES IN THERAPY · 2026 · Same journal
• An Eight-Century Evolution of Asthma Therapeutics in Western Countries: From Medieval Regimens to Anti-inflammatory Reliever Therapy and Precision Biologics · ADVANCES IN THERAPY · 2026 · Same journal
• Budget Impact of Eplerenone for Heart Failure with Reduced Ejection Fraction: National Perspective and Regional Implications in Italy · ADVANCES IN THERAPY · 2026 · Same journal
• Obstetric and Neonatal Factors Associated with Postpartum Depressive Symptoms: A Retrospective Multicenter EPDS-Based Study · ADVANCES IN THERAPY · 2026 · Same journal
• Impact of Mucopolysaccharidosis Type II in Young Children from the Caregiver’s Perspective: A Qualitative Study · ADVANCES IN THERAPY · 2026 · Same journal